Table 2.
Interventions used for treating proliferative diabetic retinopathy in patients lost to follow-up after resuming care until the end of the observation period.
| PDR treatment | Number of patients LTFU | Duration of resumed follow-up to final visit (months) | Duration of resumed follow-up to final visit (months) | Duration of resumed follow-up to final visit (months) | Duration of resumed follow-up to final visit (months) |
|---|---|---|---|---|---|
| PRP | IVI (s) | PPV | |||
| IVI | 8 | 4 | 5 | 2 | 7.3 ± 2.5 |
| PRP | 23 | 12 | 9 | 3 | 4.1 ± 1.7 |
| PRP + IVI (s) | 45 | 19 | 32 | 9 | 7.8 ± 1.1 |
IVI = intravitreal injection, LTFU = loss to follow-up, PRP = panretinal photocoagulation, PPV = pars plana vitrectomy, and PDR = proliferative diabetic retinopathy.